Hematology and Reagents
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
W40M MRC0 WEST
Contract Value
Not provided
Codes & Classification
Solicitation Number
W81K0026QA081
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents5
The Department of the Army, under the Department of Defense, has issued a Combined Synopsis/Solicitation for the procurement of a Hematology Analyzer with associated reagents and a digital cell morphology platform that interfaces directly with the analyzer. This opportunity, identified by procurement number W81K0026QA081, is managed by the W40M MRC0 WEST contracting office and is intended to support medical diagnostic capabilities at a facility located in Huntsville, Alabama.
The primary objective of this procurement is to acquire a comprehensive hematology solution that includes both the analytical instrumentation and the necessary reagents for in-vitro diagnostic use. Additionally, the requirement specifies a digital cell morphology platform that must be compatible and capable of interfacing with the hematology analyzer, ensuring seamless workflow integration and enhanced diagnostic accuracy. The scope of work and technical requirements are detailed in the Performance Work Statement (PWS) and supporting attachments, which are available for review as part of the solicitation package.
This procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with a Product Service Code of 6550, indicating a focus on medical and surgical instruments, equipment, and supplies. There are no set-aside restrictions associated with this solicitation, making it open to all qualified vendors regardless of business size or socioeconomic status.
The intended outcome of this acquisition is to equip the designated Army medical facility in Huntsville, Alabama, with state-of-the-art hematology diagnostic capabilities, supporting both routine and specialized laboratory testing. Contractors are expected to provide all necessary equipment, reagents, and interfacing digital platforms, as well as any ancillary services required for successful implementation and ongoing operation.
Interested parties are encouraged to review all solicitation attachments for comprehensive technical and performance requirements. The procurement is currently active, with a response deadline of September 4, 2026, at 17:04. For further information or clarification, potential offerors may contact the primary point of contact, Renee Combs ([email protected]), or the secondary contact, Rashonda Jones ([email protected]).
This opportunity represents a significant investment in advanced diagnostic technology for military healthcare operations and is best suited for contractors with proven expertise in hematology analyzers, reagent supply, and digital cell morphology solutions. All interested vendors should ensure their offerings meet the interoperability and performance standards outlined in the solicitation documents.
For full details and access to solicitation attachments, please refer to the official notice on SAM.gov at: https://sam.gov/opp/0735da276bb243218e7d96899d120631/view.